Top compounds associated with response to RP1-37E16.12

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	PRL-3 Inhibitor I	CTRPv2	pan-cancer	AAC	0.062	0.1
mRNA	epigallocatechin-3-monogallate	CTRPv2	pan-cancer	AAC	0.058	0.1
mRNA	SR-II-138A	CTRPv2	pan-cancer	AAC	0.05	0.1
mRNA	BRD-K33199242	CTRPv2	pan-cancer	AAC	-0.06	0.1
mRNA	Vandetanib	CTRPv2	pan-cancer	AAC	-0.056	0.1
mRNA	N9-isopropylolomoucine	CTRPv2	pan-cancer	AAC	0.057	0.2
mRNA	navitoclax:gemcitabine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.053	0.2
mRNA	nelarabine	CTRPv2	pan-cancer	AAC	0.059	0.2
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.054	0.2
mRNA	UNC0638	CTRPv2	pan-cancer	AAC	0.056	0.2

Download CSV